Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Leap Therapeutics, Inc. (LPTX)  
$0.39 0.02 (4.29%) as of 4:30 Mon 6/16


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 59,660,000
Market Cap: 23.40(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.2656 - $4.61
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Leap Therapeutics is a biopharmaceutical company developing therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways and by harnessing the immune system to attack cancer cells. Co.'s primary clinical stage program is DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1 (DKK1). DKK1 is a protein that regulates the Wnt signaling pathways and enables tumor cells to proliferate and spread, as well as suppresses the immune system from attacking the tumor. Co. is studying DKN-01 in multiple ongoing clinical trials in patients with esophagogastric cancer, gynecologic cancers, or prostate cancer.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2025-03-16 2024-12-13 2024-06-14 2023-06-15

   
Records found: 40
  Page 1 of 2  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Sirard Cynthia Chief Medical Officer   •       –      –    2025-03-28 4 OE $0.00 $0 D/D 22,500 27,500     -
   Omahony John Mark Chief Manufacturing Officer   •       –      –    2025-03-28 4 OE $0.00 $0 D/D 22,500 27,500     -
   Granfield Christine VP, Head of Reg Affairs/Qual   •       –      –    2025-03-28 4 D $0.32 $2,091 D/D (6,604) 15,896     -
   Granfield Christine VP, Head of Reg Affairs/Qual   •       –      –    2025-03-28 4 OE $0.00 $0 D/D 22,500 22,500     -
   Onsi Douglas E CEO,CFO,Pres.,GC,Treas.&Sec.   •       •      –    2025-03-28 4 OE $0.00 $0 D/D 32,500 106,146     -
   Lawlor Augustine Chief Operating Officer   •       –      –    2025-03-28 4 D $0.32 $2,469 D/D (7,797) 19,789     -
   Lawlor Augustine Chief Operating Officer   •       –      –    2025-03-28 4 OE $0.00 $0 D/D 22,500 27,586     -
   Baum Jason Chief Scientific Officer   •       –      –    2025-03-28 4 D $0.32 $2,091 D/D (6,604) 15,896     -
   Baum Jason Chief Scientific Officer   •       –      –    2025-03-28 4 OE $0.00 $0 D/D 22,500 22,500     -
   Miraelli Christopher Chairman of the Board   •       •      –    2025-03-28 4 D $0.32 $2,112 D/D (6,672) 20,914     -
   Miraelli Christopher Chairman of the Board   •       •      –    2025-03-28 4 OE $0.00 $0 D/D 22,500 27,586     -
   Miraelli Christopher Chairman of the Board   •       •      –    2024-11-13 4 OE $2.82 $6,024 I/I 2,136 678,456     -
   Onsi Douglas E CEO,CFO,Pres.,GC,Treas.&Sec.   •       •      –    2024-11-13 4 OE $2.82 $6,024 I/I 2,136 678,456     -
   Cavanaugh James H Director   –       •      –    2024-11-13 4 OE $2.82 $601 D/D 213 213     -
   Lawlor Augustine Chief Operating Officer   •       –      –    2024-11-13 4 OE $2.82 $6,024 I/I 2,136 678,456     -
   Gilead Sciences Inc 10% Owner   –       –       •   2024-04-10 3 IO $0.00 $0 D/D 0 5,319,148 -7%     
   Onsi Douglas E CEO,CFO,Pres.,GC,Treas.,&Sec.   •       •      –    2024-01-26 4 OE $0.00 $0 D/D 7,500 73,646     -
   Lawlor Augustine Chief Operating Officer   •       –      –    2024-01-26 4 OE $0.00 $0 D/D 5,000 5,086     -
   Omahony John Mark Chief Manufacturing Officer   •       –      –    2024-01-26 4 OE $0.00 $0 D/D 5,000 5,000     -
   Sirard Cynthia Chief Medical Officer   •       –      –    2024-01-26 4 OE $0.00 $0 D/D 5,000 5,000     -
   Miraelli Christopher Chairman of the Board   •       •      –    2024-01-26 4 OE $0.00 $0 D/D 5,000 5,086     -
   Onsi Douglas E CEO,CFO,Pres.,GC,Treas.,&Sec.   •       •      –    2023-03-17 4 OE $0.00 $0 D/D 660,606 661,466     -
   Beigene, Ltd. 10% Owner   –       –       •   2021-09-24 4 B $2.85 $7,249,830 D/D 2,543,800 7,348,437 2.45     -
   Healthcare Partners Viii, L.p. 10% Owner   –       –       •   2020-12-28 4 D $0.00 $0 D/D (2,618,406) 0     -
   Edelman Joseph 10% Owner   –       –       •   2020-06-22 4 B $2.00 $3,500,000 I/I 1,750,000 8,476,496 1.5     -
  40 Records found
  1  2   
  Page 1 of 2
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us